Want the short version?
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Ask OQRO reads the filings behind this page and answers in plain words, with a link to each source.
Ask OQRO is part of OQRO Pro. Everything else on OQRO is free.
Only to see which pages are hard to use, so we can fix them. Nothing is used for ads, and what you type stays hidden (Microsoft Clarity, PostHog). Privacy Policy
Roger Md Medel is Director at Opko Health. OQRO lists 1 transaction filed with the SEC under this name, the latest on Jun 22, 2026, each linked to the official Form 4.
Director
Disclosures on record
1
Companies involved
1
Roger Md Medel has no open-market purchase on record since 2006. Sales in 12 of the 21 years since 2006.
Roger Md Medel reported 0 open-market purchases and 59 sales since 2006; no open-market purchase.
| Year | Bought | Sold |
|---|---|---|
| 2022 | — | $5.39M4×4 trades |
| 2021 | — | $13.4M12×12 trades |
| 2020 | — | $2.3M2×2 trades |
| 2015 | — | $15.2M2×2 trades |
| 2014 | — | $29.7M10×10 trades |
| 2013 | — | $28.1M2×2 trades |
| 2012 | — | $11.1M2×2 trades |
| 2011 | — | $3.24M1×1 trade |
| 2010 | — | $427K2×2 trades |
| 2009 | — | $18.2M17×17 trades |
| 2007 | — | $10.3M3×3 trades |
| 2006 | — | $5.02M2×2 trades |
Open-market purchases (code P) and sales (code S) on Forms 4 and 5. Up to Sep 2024 from the SEC's Insider Transactions Data Sets; since Oct 2024 from each filing as it is published. A trade filed twice (an amendment) counts once. Dollar totals use the price the filer reported; lines with no price count as trades without a value.
Opko HealthOPK
Jun 18, 202630Kdisclosed Jun 22
DetailsOfficial recordRoger Md Medel reported 0 open-market purchases and 59 sales here, 2006 to 2022.
Closing prices and the companies' last annual figures; a − or + is a fact of the close, not a forecast.
Roger Md Medel has no open-market purchase on record since 2006. Sales in 12 of the 21 years since 2006.
In SEC filings since 2006: no open-market purchase is on record; the latest open-market sale is from 2022.
Pediatrix Medical Group (MD), from 2006 to 2022: 0 purchases and 59 sales.